HDAC6 and peripheral neuropathy: Conversely, Zhang et al. demonstrated that HDAC6 inhibitors could increase the expression of IL-10 and reverse the mechanical hypersensitivity induced by chemotherapy to treat chemotherapy-induced peripheral neuropathy (44).